Kennedy"s potential role in the Trump administration could reshape the FDA and NIH, focusing on tighter controls in the biotech sector and shifting NIH funding towards chronic diseases. His controversial views on vaccines and food policy may lead to fragmented health recommendations and cuts to key agency functions, raising concerns about public health and drug approval processes. Investors are more worried about food policy changes than pharmaceutical regulations.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
